NRS 439B.645
Pharmacy benefit manager to submit annual report concerning essential diabetes drugs.

1.

Except as otherwise provided in subsection 2, on or before April 1 of each year, a pharmacy benefit manager shall submit to the Department a report which includes:

(a)

The total amount of all rebates that the pharmacy benefit manager negotiated with manufacturers during the immediately preceding calendar year for prescription drugs included on the list compiled by the Department pursuant to subsection 1 of NRS 439B.630;

(b)

The total amount of all rebates described in paragraph (a) that were retained by the pharmacy benefit manager; and

(c)

The total amount of all rebates described in paragraph (a) that were negotiated for purchases of such drugs for use by:

(1)

Recipients of Medicare;

(2)

Recipients of Medicaid;

(3)

Persons covered by third parties that are governmental entities which are not described in subparagraph (1) or (2);

(4)

Persons covered by third parties that are not governmental entities; and

(5)

Persons covered by a plan described in subsection 2 to the extent required by a contract entered into pursuant to subsection 3.

2.

Except as otherwise provided in subsection 3, the requirements of this section do not apply to the coverage of prescription drugs under a plan that is subject to the Employee Retirement Income Security Act of 1974 or any information relating to such coverage.

3.

A plan described in subsection 2 may, by contract, require a pharmacy benefit manager that manages the coverage of prescription drugs under the plan to comply with the requirements of this section.

Source: Section 439B.645 — Pharmacy benefit manager to submit annual report concerning essential diabetes drugs., https://www.­leg.­state.­nv.­us/NRS/NRS-439B.­html#NRS439BSec645.

439B.600
Definitions. 439B.605
“Manufacturer” defined. 439B.610
“Pharmacy” defined. 439B.615
“Pharmacy benefit manager” defined. 439B.620
“Wholesale acquisition cost” defined. 439B.625
Organization representing interests of retail merchants to prepare and update list of most commonly prescribed drugs or generic equivalents. 439B.630
Department to annually compile lists of certain prescription drugs essential for treating asthma and diabetes. 439B.635
Manufacturer of certain essential diabetes drugs to prepare and submit annual report. 439B.640
Manufacturer of essential diabetes drug that has undergone significant price increase to submit report. 439B.645
Pharmacy benefit manager to submit annual report concerning essential diabetes drugs. 439B.650
Department to compile report concerning price of essential asthma and diabetes drugs. 439B.655
Pharmacies to provide to Department contact information, electronic mail address and address of Internet website 439B.660
Manufacturer required to provide list of its pharmaceutical sales representatives 439B.665
Report by certain nonprofit organizations that receive items of value from manufacturer. 439B.670
Department to place on Internet website certain information concerning pharmacies, nonprofit organizations and prescription drugs and certain reports by Department 439B.675
Manner of presentation of information. 439B.680
Immunity from civil and criminal liability. 439B.685
Regulations. 439B.690
Suspension of components of program or duties of Department if sufficient money not available 439B.695
Penalty for failure to provide information to Department.
Last Updated

Feb. 5, 2021

§ 439B.645’s source at nv​.us